Medical Disorders in Pregnancy

Anaemia in Pregnancy (Iron/Folate/B12)

IN REVIEWv3🇮🇳 India-firstPENDING CLINICAL VERIFICATION

Assess anaemia using the gestational reference range and confirm iron deficiency rather than assuming every microcytic anaemia is IDA. Distinguish preventive iron/folate from treatment; calculate the full IV replacement need and review response.

Admission & discharge ↓

Reviewer note: Medication regimens and dependent emergency instructions checked 17 October 2026. These targeted checks do not certify every statement in the module. Admission/discharge guidance checked 18 October 2026. This adds a scoped clinical synthesis and does not certify every statement in the module.

Admission & discharge

Care setting: Usually outpatient replacement; admit instability, severe symptoms or major bleeding

Admission/discharge guidance checked 2026-10-18 against the linked sources. This is a clinical checklist for an individual decision, not an automatic discharge order.

When admission or continued hospital care is needed

Admit active significant bleeding, cardiovascular compromise, syncope, severe symptoms or a need for urgent transfusion/close monitoring. Consider proximity to birth and access to definitive treatment.

When clinic, day care or home care may be suitable

Stable confirmed deficiency can usually be treated with oral iron or a planned infusion service when appropriate. The Hb value must be interpreted with symptoms, gestation and cause.

Before going home

No ongoing bleeding or physiological instability; the anaemia cause, treatment route and response plan are documented.
After IV iron or transfusion, the required observation is complete and any reaction has been assessed. Do not discharge only because an infusion finished.

Discharge medicines and treatment changes

Use a specific elemental-iron/folate prescription for confirmed IDA; assess B12/folate or other causes when indicated. Avoid duplicate oral/IV/OTC iron.
Postpartum anaemia treatment differs from a preventive supplement; specify what continues and when it is reviewed.

Medicine doses — use only when indicated

Use the medicines selected for this patient. Listed alternatives are not instructions to prescribe all of them together. Confirm the actual remaining course, pregnancy/postnatal context and monitoring plan.

For confirmed antenatal iron-deficiency anaemia.

Oral iron — treatment of pregnancy IDAWHOsummary checked

Dose120 mg ELEMENTAL iron per day (WHO treatment dose), with 400 micrograms folic acid daily

RouteOral

FrequencyDaily; divide the elemental-iron dose if needed for tolerability

DurationUntil Hb normalises, then return to the preventive antenatal dose; continue the documented postnatal/repletion plan rather than stopping after an arbitrary pack

PreparationCount ELEMENTAL iron, not total salt mass. A tablet containing 60 mg elemental iron gives 120 mg with two tablets; check combined-tablet folate content separately. Separate from calcium by several hours and from levothyroxine by 4–5 hours

Max dose120 mg/day elemental iron in this WHO treatment regimen; extra OTC iron can duplicate treatment

Indication: Confirmed iron deficiency with anaemia; exclude haemoglobinopathy/other causes and assess urgency
Daily WHO treatment and prevention doses are different. Alternate-day strategies need an explicit alternative prescription and response review.

Monitoring

Hb response after 2–4 weeks, adherence, GI effects and evidence of iron deficiency; investigate non-response and consider IV replacement when indicated

Contraindications: Iron overload or non-iron-deficiency anaemia; oral treatment is inadequate as sole treatment of unstable major bleeding

For diagnosed postpartum iron-deficiency anaemia after the acute cause is controlled.

Oral iron and folic acid — postpartum anaemia treatmentWHO / FIGO / ICM · 2025 consolidated recommendations, supportive care tablesummary checked

Dose120 mg ELEMENTAL iron plus 400 micrograms folic acid per day

RouteOral

FrequencyDaily; tailor administration for tolerance without accidentally changing the prescribed total

DurationWHO postpartum anaemia treatment: until Hb normalises. Then document any continuing preventive/repletion course and review; the preventive 6–12-week recommendation is a different indication.

PreparationUse the product’s ELEMENTAL iron content, not salt weight: two tablets each containing 60 mg elemental iron provide 120 mg. Check the combined-tablet folate separately. Separate iron from calcium by several hours and levothyroxine by 4–5 hours.

Max dose120 mg/day elemental iron in this WHO treatment schedule; do not add duplicate antenatal/OTC iron or overlap oral and IV courses without an explicit plan.

Indication: Diagnosed postpartum iron-deficiency anaemia after haemorrhage is controlled and outpatient oral treatment is suitable
The WHO 2025 supportive-care recommendation supplies the postpartum dose/endpoint. Preparation and response monitoring reuse the checked oral-iron reference; breastfeeding is compatible with indicated maternal supplementation.

Monitoring

Arrange Hb response review after 2–4 weeks, tolerance and adherence; investigate non-response or ongoing bleeding and reassess the replacement route.
Review the cause of anaemia and any coexisting B12/folate deficiency or haemoglobinopathy.

Contraindications: Iron overload or anaemia without iron deficiency; oral iron alone is inadequate for unstable bleeding or cardiovascular compromise.

Tests, pending results and their reviewer

Record Hb/indices and relevant deficiency investigations; repeat Hb after about 2–4 weeks of oral treatment and investigate an inadequate response.

Home care and counselling

Discuss administration, side effects, adherence, diet and how to access the next test or infusion.

Follow-up: when and what to review

When	Action / responsible service
2–4 weeks after starting oral treatment	Check Hb response, tolerance and adherence; reassess the diagnosis if response is inadequate.
Before birth / after major blood loss	Reassess urgency, replacement progress and any specialist/transfusion plan.

Return urgently

New chest pain, breathlessness at rest, fainting, rapid deterioration or recurrent heavy bleeding requires urgent assessment.

Open the complete discharge checklist →

Sources for this plan:

WHOsummary checked CSL Vifor / emcchecked WHO / FIGO / ICM · 2025 consolidated recommendations, supportive care tablesummary checked

Treatment

① Immediate stabilization — first minutes

Symptomatic severe anaemia near birth: transfuse (target ~8-9 pre-delivery context) + treat cause simultaneously

③ First-line treatment & drug regimens

Oral iron — treatment of pregnancy IDAWHOsummary checked

Dose120 mg ELEMENTAL iron per day (WHO treatment dose), with 400 micrograms folic acid daily

RouteOral

FrequencyDaily; divide the elemental-iron dose if needed for tolerability

DurationUntil Hb normalises, then return to the preventive antenatal dose; continue the documented postnatal/repletion plan rather than stopping after an arbitrary pack

Max dose120 mg/day elemental iron in this WHO treatment regimen; extra OTC iron can duplicate treatment

Confirmed iron deficiency with anaemia; exclude haemoglobinopathy/other causes and assess urgency
Daily WHO treatment and prevention doses are different. Alternate-day strategies need an explicit alternative prescription and response review.

Monitoring

Hb response after 2–4 weeks, adherence, GI effects and evidence of iron deficiency; investigate non-response and consider IV replacement when indicated

Contraindications: Iron overload or non-iron-deficiency anaemia; oral treatment is inadequate as sole treatment of unstable major bleeding

Ferric carboxymaltose — IV infusionCSL Vifor / emcchecked

DoseDetermine TOTAL need from Hb and weight, then give up to 20 mg/kg per infusion, not exceeding 1000 mg

RouteIV infusion only

FrequencyRepeat only if calculated deficit remains; additional dose at least 7 days later

DurationFinite replacement course, not automatic weekly indefinite treatment

Preparation50 mg iron/mL: 1000 mg =20 mL. For >500–1000 mg dilute only in up to 250 mL sodium chloride 0.9% and infuse over at least 15 min. Do not dilute below 2 mg/mL

Max doseLesser of 20 mg/kg or 1000 mg per infusion; maximum 1000 mg/week for adults in this Ferinject label

Laboratory-confirmed iron deficiency when oral iron is ineffective/intolerable or faster replacement is indicated; assess trimester and infection
Label total-need table: Hb <10 g/dL: 35–<70 kg 1500 mg, ≥70 kg 2000 mg. Hb 10–<14: 1000 mg and 1500 mg respectively. Hb ≥14: 500 mg. Below 35 kg: use the label weight-based calculation.
A 60 kg patient with Hb 8 g/dL therefore needs 1500 mg TOTAL, split 1000 mg then 500 mg ≥7 days later; 1000 mg is not automatically the full deficit.

Monitoring

Observe during and at least 30 min after infusion with anaphylaxis treatment available; monitor extravasation
Hb reassessment no earlier than 4 weeks after final dose; phosphate for repeated/high-dose courses or symptoms

Contraindications: Non-iron-deficiency anaemia, iron overload or serious parenteral-iron hypersensitivity · Restrict pregnancy treatment to clear indications in the second/third trimester; avoid during ongoing bacteraemia

Iron–folic acid — antenatal preventionWHOsummary checked

Dose60 mg ELEMENTAL iron +400 micrograms (0.4 mg) folic acid

RouteOral

FrequencyOnce daily

DurationThroughout pregnancy, beginning as early as possible; document any national postpartum continuation separately

PreparationChoose a product labelled with these elemental-iron/folate amounts; no dilution. Check other prenatal supplements to avoid duplication; separate calcium and levothyroxine

Max doseWHO preventive range is 30–60 mg elemental iron/day; this card selects 60 mg. Do not treat established IDA with the preventive dose alone

Routine pregnancy supplementation, particularly high-anaemia-burden settings
Start folic acid before conception where possible. High-risk neural-tube-defect prevention is a separate higher-dose folate prescription.

Monitoring

Hb/anaemia screening, tolerance, adherence and additional risk of folate/B12 deficiency

Contraindications: Known iron overload; assess microcytosis/non-response rather than repeatedly escalating iron blindly

Definitive treatment

Store repletion + cause correction (bleeding, diet, deworming per programme).

Monitoring

Hb 2-4 wks after change
Individualised transfusion thresholds

Response assessment

>=1 g/dL per fortnight oral; symptom improvement

Treatment failure

Non-response: adherence, blockers, occult loss, alternative dx -> switch IV

Second-line treatment

IV pathway; haematology referral uncertainty

Rescue treatment

Cardiac-compromised: slow PRBC transfusion; equipped-unit birth planning.

Escalation

Haemoglobinopathy pregnancies -> haematology co-care

⑮ Complications & their management

PPH amplification

Correct BEFORE birth - strongest modifiable PPH-death factor locally

PTB/LBW associations

Timely correction reduces risk

Post-treatment care

Iron continues 3 months postpartum
Family haemoglobinopathy screening

Diagnosis & assessment

Red flags:

Hb <7 or cardiac symptoms -> transfusion consideration + IV iron
Unresolved bleeding source stacking PPH risk
Microcytosis with normal-high ferritin -> thalassaemia workup FIRST

Definition: WHO pregnancy anaemia <11.0 g/dL; severe <7.0.

Initial assessment

CBC indices + smear
Iron studies (ferritin +/- TSAT)
B12/folate when macrocytic/mixed
HPLC/electrophoresis where indicated

Investigations

Test	Looking for
Ferritin	<30 ng/mL supports absolute deficiency
HPLC	Beta-thal trait / variants

Principles & follow-up

Management principles

Sources (9)

WHO — WHO recommendations on antenatal care for a positive pregnancy experience (+ updates: MMN supplements, vitamin D, zinc, ultrasound before 24 weeks; WHO Maternal Health recommendations 2nd ed 2025)
2016; updates 2020–2025 (2nd ed maternal-health compendium 2025-03) · checked 2026-08-23 · verified-live
Open source ↗

WHO pages + NCBI compendium: daily IFA 30–60 mg elemental iron + 400 µg folic acid; intermittent IFA only where daily not acceptable & anaemia prevalence <20%; anaemia in ANC → 120 mg elemental iron daily until Hb normal; MMS recommended only within rigorous research contexts (supersedes 2016); ≥8 c…

WHO — Antenatal care recommendations — iron and folate doses
· checked 2026-10-17 · verified-summary
Open source ↗

Recommendation A.2.1: prevention 30–60 mg elemental iron plus 400 micrograms folic acid daily; anaemia treatment 120 mg elemental iron with 400 micrograms folic acid until Hb normal, then prevention. Limited dose-scope check through the primary WHO text indexed by NCBI; not a revalidation of every 2…

CSL Vifor / emc — Ferinject 50 mg iron/mL
· checked 2026-10-18 · verified-live
Open source ↗

Hb/weight total-need table, 20 mg/kg and 1000 mg infusion limits, ≥7-day spacing, saline-only dilution, ≥15-minute infusion for >500 mg, ≥30-minute observation, phosphate and pregnancy cautions. Additional admission/discharge check 18 October 2026 (limited to the following): At least 30-minute monit…

WHO / FIGO / ICM — Postpartum haemorrhage consolidated guideline — supportive postpartum iron care
· checked 2026-10-18 · verified-summary
Open source ↗

Primary recommendation table indexed at NCBI Bookshelf checked: postpartum diagnosed anaemia 120 mg elemental iron plus 400 micrograms folic acid daily until Hb normal; preventive 6–12 weeks is a separate indication. Direct table retrieval presented a browser check, so this is a limited primary-text…

NICE — Postnatal care — NG194
· checked 2026-10-18 · verified-live
Open source ↗

Maternal/newborn transfer assessment, first void and effective feeding, handover, support/safeguarding, first midwife visit within 36 hours after transfer, postnatal danger symptoms. Full recommendations page read.

India MoHFW / NHM — District Hospital Standard Operating Procedures — LaQshya
· checked 2026-10-18 · verified-live
Open source ↗

Normal-delivery discharge not less than 48 hours: full primary SOP PDF normal-delivery/discharge passages read. Corroborated by NHM CEmONC 2024 Part 1, chapter 8. This does not define a universal post-caesarean or complicated-case stay.

WHO — WHO recommendations on quality postnatal care — official recommendation summary
· checked 2026-10-18 · verified-live
Open source ↗

Official WHO summary read: at least 24-hour facility care after birth; additional contacts at 48–72 hours, 7–14 days and week 6; individual assessment/support. Summary facts only, not a claim that the full 242-page PDF was reviewed.

RCOG — Laparoscopy — recovering well
· checked 2026-10-18 · verified-live
Open source ↗

Full primary patient recovery page read: pain control, wounds, activity/VTE, urinary/bowel and infection warning signs, adult support and no driving/important decisions during the first 24 hours after general anaesthesia. Used as general recovery/handover principles, not operation-specific discharge…

NICE — Acutely ill adults in hospital — CG50
· checked 2026-10-18 · verified-live
Open source ↗

Full primary recommendations read, focusing on critical-care-to-ward transfer: structured written handover, shared plan, monitoring, rehabilitation and receiving-team capability. Step-down is distinct from home discharge; no universal organ-support discharge cutoff is asserted.